As an example, a 3D‐nanopatterned microfluidic chip allowed for the detection, in 2‐μL plasma samples from ovarian cancer patients, of exosome subpopulations expressing CD24, EpCAM and FR‐α proteins as potential biomarkers for ovarian cancer.36 The gene discussed is CD24; the disease is ovarian cancer.